Enhancing the public health impact of latent TB infection diagnosis and treatment: A pragmatic cluster randomized trial.
Click here to access the protocol.
Click here for training material.
Click here for registry analysis tool.
Click here for mTST material.
Click here for publications.
A randomized clinical trial of 4 months Rifampin vs. 9 months Isoniazid for latent TB infection (Phase 3 effectiveness)
&
A randomized trial to compare completion and tolerability of 4 months Rifampin (4 RIF) and 9 months Isoniazid (9 INH) for treatment of latent TB in children
Click here to have more details on the protocol
Click here to have access to the RCT 4v9 children publication
Click here to have access to the RCT 4v9 adult publication
Meta-analysis of Individual patient Data (IPD) of Patients with INH (mono or poly-drug) Resistant Tuberculosis. Click here to read the study protocol
Meta-analysis of Individual patient Data (IPD) of Patients with Multi-Drug Resistant Tuberculosis. Click here for resources related to this project.
Partnerships
![]() |
PAHO/WHO Collaborating Centerswww.paho.org/collaboratingcenters
|
|
Advancing New TB Vaccines for the Worldwww.aeras.org/ |
|
Our vision: A world where diagnosis guides the way to health for all peopleOur mission: Turning complex diagnostic challenges into simple solutions to overcome diseases of poverty and transform liveswww.finddx.org/ |
![]() |
Manipal Centre for Infectious Disease based at Manipal University, Karnataka, Indiahttps://manipal.edu/mu.html |
![]() |
SGC is a public-private partnership that supports the discovery of new medicines through open access research.www.thesgc.org/ |
![]() |
TB REACH: FINDING AND TREATING PEOPLE WITH TB IN THE WORLD’S POOREST COMMUNITIESwww.stoptb.org/global/awards/tbreach/
Partnership involvement |
![]() |
TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster-acting, and affordable tuberculosis drugs that are available to those who need them.www.tballiance.org/ |